medigraphic.com
Revista Médica Sinergia

2024, Number 02

<< Back Next >>

Revista Médica Sinergia 2024; 9 (02)

Ductal carcinoma in situ of the breast

Montagné-Bonilla N, Soto-Harvey N, Huete-Echandi F

Language: Spanish
References: 16
Page:
PDF size: 157.39 Kb.


ABSTRACT

Ductal carcinoma in situ (DCIS) of the breast is defined as a conglomerate of abnormal epithelial cells, which are presumed to be malignant cells, and which are confined in the breast ducts and lobes without invading the basement membrane or myoepithelial cells surrounding the breast ductolobulillar system. There are no specific clinical manifestations of DCIS. Most patients present with an abnormal mammogram, asymptomatic and without physical examination findings. More than 90% of all cases of DCIS are detected only by images and subsequently the diagnosis is confirmed using a biopsy. Breast conserving therapy is generally the treatment of choice. Fortunately, the DCIS has an excellent prognosis with adequate multidisciplinary treatment.


REFERENCES

  1. Collins L, Laronga C, Wong J. Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis. UpToDate [Internet]. 2019 [citado el 14 diciembre 2023]. Disponible en: https://www.uptodate.com/contents/breast-ductal-carcinoma-in-situ-epidemiology-clinical-manifestations-and-diagnosis?topicRef=14221&source=see_link#

  2. Nash AL, Hwang ES. The Landmark Series-Ductal Carcinoma in Situ: The Evolution of Treatment. Ann Surg Oncol [Internet]. 2023 [citado el 14 diciembre 2023]:3206-3214. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37024766/

  3. Chelariu-Raicu A, Harbeck N. Treatment Landscape of Ductal Carcinoma In Situ. Chirurgia (Bucur) [Internet]. 2021 [citado el 14 diciembre 2023]:S76-S82. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34967314/

  4. Narod S Iqbal J Giannakeas V Sopik V Sun P. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ. Jama Oncology [Internet]. 2015 [citado el 14 diciembre 2023]:1-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26291673/

  5. Coleman W. Breast Ductal Carcinoma in Situ Precursor to Invasive Breast Cancer. The American Journal of Pathology [Internet]. 2019 [citado el 14 diciembre 2023]:942-945. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31029232/

  6. Craig Allred D. Ductal Carcinoma In Situ: Terminology, Classification, and Natural History. Journal of the National Cancer Institute Monographs [Internet]. 2010 [citado el 14 diciembre 2023];41:134-138. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20956817/

  7. Calderón JM, Febles G. Actualidad para el diagnóstico del carcinoma ductal in situ:correlación radiopatológica. Horiz Med [Internet]. 30 de marzo, 2017 [citado el 14 diciembre 2023];17(1):57-65. Disponible en: https://www.horizontemedico.usmp.edu.pe/index.php/horizontemed/article/view/564

  8. Iatrakis G, Zervoudis S. Epidemiology of Ductal Carcinoma In Situ. Chirurgia (Bucur) [Internet]. 2021 [citado el 14 diciembre 2023]:S15-25. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34967307/

  9. Fu FM, Gilmore R, Jacobs L. Ductal Carcinoma In Situ. Surgical Clinics of North America [Internet]. 2018 [citado el 14 diciembre 2023]:725-745. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30005770/

  10. Mulholland M, Lillmoe K, Doherty G, Upchurch G, Allam H, Pawlik T. Greenfield’s Surgery: Scientific Principles & Practice. Philadelphia, PA: Lippincott Williams & Wilkins. 2017; 6th ed.

  11. Lisencu C, Lesaru M. Ductal Carcinoma In Situ. Interventional Diagnosis. Chirurgia (Bucur) [Internet]. 2021 [citado el 14 diciembre 2023]:S50-S58. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34967311/

  12. Mena G, Benavides R, Freire A, Naranjo A. Biopsia de mama con guía estereotáxica digital directa, revisión y actualidad. Colegio Interamericano de Radiología. 2018 [citado el 14 diciembre 2023];9(1). Disponible en: https://www.webcir.org/revistavirtual/ec_a18_vol09_n01_1.php

  13. Haji F, Baker JL, DiNome ML. Updates on treating ductal carcinoma in situ: what's to know in 2021. Curr Opin Obstet Gynecol [Internet]. 2022 [citado el 14 diciembre 2023]:46-51. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34545016/

  14. Shah C, Bremer T, Cox C, Whitworth P, Patel R, Patel A, Brown E, Gold L, Rock D, Riley L, Kesslering C, Brown S, Gabordi R, Pellicane J, Rabinovich R, Khan S, Templeton S, Majithia L, Willey SC, Wärnberg F, Gerber NK, Shivers S, Vicini FA. The Clinical Utility of DCISionRT® on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery. Ann Surg Oncol [Internet]. 2021 [citado el 14diciembre 2023]:5974-5984. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526470/

  15. Hong Y, McMasters K, Egger M, Ajkay N, Polk H. Ductal Carcinoma In Situ Current Trends, Controversies, and Review of Literature. The American Journal of Surgery [Internet]. 2018 [citado el 14 diciembre 2023]:1-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30244816/

  16. Collins L, Laronga C Wong J. Ductal carcinoma in situ: Treatment and prognosis. UpToDate [Internet]. 2019 [citado el 14 septiembre 2023]. Disponible en: https://www.uptodate.com/contents/ductal-carcinoma-in-situ-treatment-and-prognosis




2020     |     www.medigraphic.com